Day: July 29, 2020

• Revenue:$46.5 million for Q2 2020$93.0 million for H1 2020• Net cash from operating activities:$26.7 million for Q2 2020$47.7 million for H1 2020• Adjusted EBITDA:$14.3 million for Q2 2020$33.4 million for H1 2020• Acquired five drybulk vessels following the liquidation of Navios Europe II• $0.05 per unit cash distribution for Q2 2020MONACO, July 29, 2020 (GLOBE NEWSWIRE) — Navios Maritime Partners L.P. (“Navios Partners”) (NYSE: NMM), an international owner and operator of dry cargo vessels, today reported its financial results for the second quarter and six month periods ended June 30, 2020.Angeliki Frangou, Chairman and Chief Executive Officer of Navios Partners, stated, “While the Pandemic greatly affected businesses, countries, and people all over the world, the Navios family continues to persevere. For the second quarter...

NESS ZIONA, Israel, July 29, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, will report second quarter 2020 financial results on Thursday, August 6, 2020 at 7:05 AM ET.About Sol-Gel TechnologiesSol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Sol-Gel leverages its proprietary microencapsulation technology platform for Twyneo, for the treatment of acne vulgaris, and Epsolay, for the treatment of papulopustular rosacea. The Company’s pipeline also includes SGT-210, an early-stage topical...

CHARLESTON, S.C., July 29, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna Zentaris” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that on July 27, 2020, the Company received notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon a closing bid price of less than $1.00 per share for the Company’s common stock for the prior 30 consecutive business day period, the Company no longer satisfies Nasdaq Listing Rule 5550(a)(2) (the “Rule”).In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a grace period of 180 calendar days, through January 25, 2021, to evidence compliance with the Rule....

CALGARY, Alberta, July 29, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) will host a live conference call to discuss second quarter results on Thursday, August 6, 2020 at 7 am MDT (9 am EDT, 6 am PDT).The conference call will include a brief presentation from FLYHT’s CEO Bill Tempany and CFO Alana Forbes followed by a question and answer session.To access the conference call by phone within Canada and the U.S.A., the toll-free number is 1-800-319-4610. Outside Canada and the U.S.A., dial 1-604-638-5340. Callers should dial in 5 to 10 minutes prior to the scheduled start time.Management will accept questions by telephone and e-mail. Individuals wishing to ask a question during the call can do so by pressing *1. Questions can be emailed in advance or during the conference...

SALT LAKE CITY, July 29, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today that the company has launched its proprietary AMPLIFY™ technology, which further increases the performance of its Prequel™ noninvasive prenatal screening (NIPS) test. The proprietary AMPLIFY process increases the fetal fraction of a NIPS sample by preferentially sequencing the fetal cell-free DNA fragments that circulate in a mother’s blood. AMPLIFY technology enables more accurate detection of fetal chromosome abnormalities. In the analytical validation involving samples from more than 1,000 pregnant women, fetal fraction is 2.3 times greater on average with AMPLIFY than with standard NIPS. This improvement reduces false positive and false negative results—including for...

Read full releaseMIAMI, FL, July 29, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the expansion of the Company’s PharmCo branded pharmacy operations and presence in the Orlando metropolitan area. The Company is moving out of its current Orlando pharmacy location, which is a 700 square-foot mini-pharmacy operating under the “Five Star” brand designation, to a 3,700 square-foot full-size pharmacy that will open under the PharmCo brand designation.The Company is also very pleased to report that this move, which represents an expansion in property size of more than 400%, will not increase monthly lease costs.Carlos Rangelcarlosr@pharmcorx.com

BARRIE, Ontario, July 29, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it will supply premium, pharmaceutical-quality cannabis products to Hybrid Pharm Inc. (“Hybrid Pharm”), a modern wellness pharmacy and medical cannabis sales licence holder serving patients in the Ottawa region.Partnering with MediPharm Labs as a trusted supplier, Hybrid Pharm is unique among pharmacies in Canada in that it provides medical cannabis patients with a full in-store experience including consultation services. Hybrid Pharm’s qualified pharmacists work closely with healthcare practitioners to provide same day registration and delivery,...

PETAH TIKVA, Israel, July 29, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announces the award of a cellular backhaul project for Kcell, Kazakhstan’s largest Mobile Network Operator (MNO). Gilat will provide connectivity starting with hundreds of rural villages, in partnership with Kazakhstan’s recognized service provider, TelService LTD, to satisfy the “Digital Kazakhstan” government program.“We are pleased to be utilizing Gilat’s globally recognized cellular backhaul solution over satellite, to provide rural coverage to the villages which require voice and data services,” said Chief Technical Officer, Mr. Askar Yesserkegenov at Kcell. “We are honored to be part of the ‘Digital...

RESEARCH TRIANGLE PARK, N.C., July 29, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that it will host a webcast and conference call to provide a corporate and financial update for the second quarter of 2020 on Wednesday, August 5, 2020 at 5:00 p.m. ET.The live call may be accessed by dialing 866-763-6020 (domestic) or 210-874-7713 (international) and entering the conference code: 4648036. The live and archived webcast will be available on the Events & Presentations page of the G1 website.About G1 TherapeuticsG1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of innovative therapies that improve the lives of those affected by cancer. The company is advancing three clinical-stage programs. Trilaciclib...

BARRIE, Ontario, July 29, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that MediPharm Labs’ management will participate in the “Cannabis Chronicles” Fireside Chat with Alliance Global Senior Analyst Aaron Grey on Friday, July 31st. What: Audio Video Webcast PresentationWhen: Friday, July 31, 2020 at 10:30am Eastern TimeWhere: Webcast link https://us02web.zoom.us/webinar/register/WN_2dREgIgnSIezAIifIZD6kg or through the events section of MediPharm Labs Investor Relations website at https://ir.medipharmlabs.com/ir-calendar.About MediPharm LabsFounded in 2015, MediPharm Labs specializes in the production of...